Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study

Abstract Background Electronic collection of patient-reported outcomes (ePROs) is becoming widespread in health care, but the implementation into routine cancer care during therapy remains to be seen. Especially, little is known of the use and success of electronic reporting during active cancer tre...

Full description

Bibliographic Details
Main Authors: Gry Assam Taarnhøj, Henriette Lindberg, Line Hammer Dohn, Lise Høj Omland, Niels Henrik Hjøllund, Christoffer Johansen, Helle Pappot
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Health and Quality of Life Outcomes
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12955-020-01480-3
_version_ 1818317694959616000
author Gry Assam Taarnhøj
Henriette Lindberg
Line Hammer Dohn
Lise Høj Omland
Niels Henrik Hjøllund
Christoffer Johansen
Helle Pappot
author_facet Gry Assam Taarnhøj
Henriette Lindberg
Line Hammer Dohn
Lise Høj Omland
Niels Henrik Hjøllund
Christoffer Johansen
Helle Pappot
author_sort Gry Assam Taarnhøj
collection DOAJ
description Abstract Background Electronic collection of patient-reported outcomes (ePROs) is becoming widespread in health care, but the implementation into routine cancer care during therapy remains to be seen. Especially, little is known of the use and success of electronic reporting during active cancer treatment in fragile and comorbid patients. The aim of this study was to test the feasibility of ePRO and its incorporation into routine cancer care, measured by physician compliance, for a fragile and comorbid bladder cancer (BC) population receiving chemo- or immunotherapy. Methods All BC patients initiating treatment for locally advanced or metastatic bladder cancer at Rigshospitalet or Herlev Hospital, Denmark, were approached during an 8 month period. Exclusion criteria were patients not speaking Danish or not being signed up for electronic communication with health authorities. Enrolled patients were prompted to complete weekly ePROs from home. Patients completed the European Organisation for Research and Treatment of Cancer’s general quality of life questionnaire, QLQ-C30, and the module for muscle-invasive bladder cancer QLQ-BLM30, the Hospital Anxiety and Depression Scale, HADS, and selected items from the Patient Reported-Outcomes version of the Common Terminology Criteria of Adverse Events (PRO-CTCAE), in total 158 questions weekly. If failing to report when prompted, patients were sent two e-mail reminders. Patients were informed that the physician would have an overview of the reported ePROs at their following clinical visits. Physicians were at all clinical visits informed to look at the ePROs in a software solution separate from the medical records. Physicians were logged to check their compliance to the task. No continuous surveillance of ePROs was established. Results Of 91 patients screened for enrolment, 19 patients (21%) were not found eligible for standard treatment, eight patients (9%) were not signed up for electronic communication with the health authorities and nine patients (10%) declined participation. Another six patients did not meet other inclusion criteria. In total 49 BC patients were enrolled, 29 initiating chemotherapy and 20 initiating immunotherapy. A total of 466 electronic questionnaires were completed. The overall adherence of the patients to complete ePROs was at an expected level for an elderly cancer population (75%) and remained above 70% until the 6th cycle of treatment. The physician’ compliance was in contrast low (0–52%) throughout the course of treatment. Conclusions Electronic reporting of PROs is feasible in a fragile and comorbid population of patients during routine active cancer treatment. Despite clear implementation strategies the physician compliance remained low throughout the study proving the need for further implementation strategies.
first_indexed 2024-12-13T09:41:24Z
format Article
id doaj.art-2348ecfc4dfd4589ab09435341e7dd51
institution Directory Open Access Journal
issn 1477-7525
language English
last_indexed 2024-12-13T09:41:24Z
publishDate 2020-07-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj.art-2348ecfc4dfd4589ab09435341e7dd512022-12-21T23:52:11ZengBMCHealth and Quality of Life Outcomes1477-75252020-07-011811910.1186/s12955-020-01480-3Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility studyGry Assam Taarnhøj0Henriette Lindberg1Line Hammer Dohn2Lise Høj Omland3Niels Henrik Hjøllund4Christoffer Johansen5Helle Pappot6Department of Oncology, University of CopenhagenDepartment of Oncology, University of Copenhagen, Herlev HospitalDepartment of Oncology, University of Copenhagen, Herlev HospitalDepartment of Oncology, University of CopenhagenAmbuFlex/WestChronic, Occupational Medicine, University Research Clinic, Aarhus UniversityDepartment of Oncology, University of CopenhagenDepartment of Oncology, University of CopenhagenAbstract Background Electronic collection of patient-reported outcomes (ePROs) is becoming widespread in health care, but the implementation into routine cancer care during therapy remains to be seen. Especially, little is known of the use and success of electronic reporting during active cancer treatment in fragile and comorbid patients. The aim of this study was to test the feasibility of ePRO and its incorporation into routine cancer care, measured by physician compliance, for a fragile and comorbid bladder cancer (BC) population receiving chemo- or immunotherapy. Methods All BC patients initiating treatment for locally advanced or metastatic bladder cancer at Rigshospitalet or Herlev Hospital, Denmark, were approached during an 8 month period. Exclusion criteria were patients not speaking Danish or not being signed up for electronic communication with health authorities. Enrolled patients were prompted to complete weekly ePROs from home. Patients completed the European Organisation for Research and Treatment of Cancer’s general quality of life questionnaire, QLQ-C30, and the module for muscle-invasive bladder cancer QLQ-BLM30, the Hospital Anxiety and Depression Scale, HADS, and selected items from the Patient Reported-Outcomes version of the Common Terminology Criteria of Adverse Events (PRO-CTCAE), in total 158 questions weekly. If failing to report when prompted, patients were sent two e-mail reminders. Patients were informed that the physician would have an overview of the reported ePROs at their following clinical visits. Physicians were at all clinical visits informed to look at the ePROs in a software solution separate from the medical records. Physicians were logged to check their compliance to the task. No continuous surveillance of ePROs was established. Results Of 91 patients screened for enrolment, 19 patients (21%) were not found eligible for standard treatment, eight patients (9%) were not signed up for electronic communication with the health authorities and nine patients (10%) declined participation. Another six patients did not meet other inclusion criteria. In total 49 BC patients were enrolled, 29 initiating chemotherapy and 20 initiating immunotherapy. A total of 466 electronic questionnaires were completed. The overall adherence of the patients to complete ePROs was at an expected level for an elderly cancer population (75%) and remained above 70% until the 6th cycle of treatment. The physician’ compliance was in contrast low (0–52%) throughout the course of treatment. Conclusions Electronic reporting of PROs is feasible in a fragile and comorbid population of patients during routine active cancer treatment. Despite clear implementation strategies the physician compliance remained low throughout the study proving the need for further implementation strategies.http://link.springer.com/article/10.1186/s12955-020-01480-3Patient-reported outcomesePROBladder cancerChemotherapyImmunotherapyFeasibility
spellingShingle Gry Assam Taarnhøj
Henriette Lindberg
Line Hammer Dohn
Lise Høj Omland
Niels Henrik Hjøllund
Christoffer Johansen
Helle Pappot
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
Health and Quality of Life Outcomes
Patient-reported outcomes
ePRO
Bladder cancer
Chemotherapy
Immunotherapy
Feasibility
title Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
title_full Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
title_fullStr Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
title_full_unstemmed Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
title_short Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
title_sort electronic reporting of patient reported outcomes in a fragile and comorbid population during cancer therapy a feasibility study
topic Patient-reported outcomes
ePRO
Bladder cancer
Chemotherapy
Immunotherapy
Feasibility
url http://link.springer.com/article/10.1186/s12955-020-01480-3
work_keys_str_mv AT gryassamtaarnhøj electronicreportingofpatientreportedoutcomesinafragileandcomorbidpopulationduringcancertherapyafeasibilitystudy
AT henriettelindberg electronicreportingofpatientreportedoutcomesinafragileandcomorbidpopulationduringcancertherapyafeasibilitystudy
AT linehammerdohn electronicreportingofpatientreportedoutcomesinafragileandcomorbidpopulationduringcancertherapyafeasibilitystudy
AT lisehøjomland electronicreportingofpatientreportedoutcomesinafragileandcomorbidpopulationduringcancertherapyafeasibilitystudy
AT nielshenrikhjøllund electronicreportingofpatientreportedoutcomesinafragileandcomorbidpopulationduringcancertherapyafeasibilitystudy
AT christofferjohansen electronicreportingofpatientreportedoutcomesinafragileandcomorbidpopulationduringcancertherapyafeasibilitystudy
AT hellepappot electronicreportingofpatientreportedoutcomesinafragileandcomorbidpopulationduringcancertherapyafeasibilitystudy